Primary Record
Androstanolone
- In stock
- 1,526 g
- Purity
- 98.5 %
- CAS
- 521-18-6
Compound Identifiers & Properties
- CAS
- 521-18-6
- PubChem CID
- 10635
- SMILES
- C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C
- Canonical SMILES
- C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
Names & Synonyms
- Androstanolone
- STANOLONE
- dihydrotestosterone
- Anabolex
- Andractim
- Androlone
- Neodrol
- Anaboleen
- Stanaprol
- Proteina
- Protona
- Cristerona MB
- 4-Dihydrotestosterone
- Androstanolona
- Androstanolonum
- 5alpha-Dihydrotestosterone
- Androstalone
- Stanorone
- Stanolon
- Dihydrotestosteron
- 5alpha-DHT
- Testosterone, dihydro-
- Anaprotin
- Drolban
- Andrin
- 5-alpha-Dihydrotestosterone
- 17beta-Hydroxy-5alpha-androstan-3-one
- 521-18-6
- 4,5alpha-Dihydrotestosterone
- Stanolone [BAN]
- 1kdk
- 2ama
- 5alpha-Androstan-17beta-ol-3-one
- dihydrotestosterone (dht)
- Andractim (TN)
- 5-a-Androstanolone
- 5a-Dihydrotestosterone
- Androstanolone [INN]
- 5 alpha DHT
- 5-alpha-DHT
- [3H]dihydrotestosterone
- Androstan-17beta-ol-3-one
- 5alpha-Androstanolone
- 17beta-Hydroxy-3-androstanone
- 5alpha-dihydrotesosterone
- Androstanolone (DHT)
- Androstanolone (INN)
- 5alpha-Dihydroxytestosterone
- [3H]-dihydrotestosterone
- 5alpha dihydrotestosterone
- 5-alpha-Androstanolone
- 17beta-Hydroxyandrostan-3-one
- 1d2s
- 1t5z
- 1t7r
- Androstanolonum [INN-Latin]
- alpha-Dihydrotestosterone
- Androstanolona [INN-Spanish]
- STANOLONE [MI]
- 4,5-alpha-Dihydrotestosterone
- AC1L1VMJ
- 4,5a-Dihydrotestosterone
- RefChem:587772
- 5.alpha.-Dihydrotestosterone
- 5-.alpha.-Androstanolone
- 5 beta Dihydrotestosterone
- Androstan-17b-ol-3-one
- (BETA)-VALIENAMINE
- DTXSID9022364
- LG 152
- CHEBI:16330
- CHEMBL27769
- D04DJN
- D0TH5I
- Epitope ID:135868
- 5 alpha Dihydrotestosterone
- 5 alpha-Dihydrotestosterone
- 5-alpha Dihydrotestosterone
- 5alpha,17beta-Hydroxyandrostan-3-one
- Testosterone EP Impurity F
- UNII-08J2K08A3Y
- 17-Hydroxyandrostan-3-one
- AC1Q6OL8
- DTXCID202364
- NVKAWKQGWWIWPM-ABEVXSGRSA-N
- 08J2K08A3Y
- 17b-Hydroxy-3-androstanone
- 4,5.alpha.-Dihydrotestosterone
- BIDD:PXR0075
- DEA No. 4000
- Dihydrotestosterone, 5-alpha
- NSC 10972
- NSC-10972
- SCHEMBL15163
- [3H]DHT
- 17-Hydroxy-androstan-3-one
- 17beta-Hydroxy-androstan-3-one
- 521-18-6 (free)
- MLS001304063
- 5a-Androstan-17b-ol-3-one
- BIDD:ER0136
- 17.beta.-Hydroxy-3-androstanone
- 5.alpha.-Dihydroxytestosterone
- 5A-Androstan-3-on-17B-ol
- 5B-Androstan-3-on-17B-ol
- EINECS 208-307-3
- 5alpha,17eta-Hydroxyandrostan-3-one
- ANDROSTANOLONE [MART.]
- Androstan-17.beta.-ol-3-one
- GTPL2856
- GTPL3455
- orb2647466
- 5-alpha-Androstan-17-beta-ol-3-one
- ANDROSTANOLONE [WHO-DD]
- 17-beta-hydroxyandrostan-3-one
- NSC10972
- THERAPEUTIC ANDROSTANOLONE
- 17-beta-Hydroxy-5-alpha-androstan-3-one
- BDBM18161
- A14AA01
- G03BB02
- 17beta-Hydroxy-5alpha-androstane-3-one
- 1t63
- (+)-Androstan-17beta-ol-3-one
- DHT
- HMS2272H05
- LG152
- 5alpha-Androstan-3-one, 17beta-hydroxy-
- 5alpha-Dihydrotestosterone degrees
- AMY22298
- C19H30O2
- CID10635
- HY-A0120
- ZINC3814360
- Tox21_111056
- Tox21_200987
- Tox21_303655
- 17|A-Hydroxy-5|A-androstan-3-one
- 5.alpha.-Androstan-17.beta.-ol-3-one
- BDBM50366473
- CMC_13452
- LMST02020042
- MSK8502-100A
- NCGC00091013-01
- s4757
- (+)-Androstan-17.beta.-ol-3-one
- (5alpha,17beta)-17-hydroxyandrostan-3-one
- 5-alpha-Androstan-3-one, 17-beta-hydroxy-
- 17beta-Hydroxy-5alpha-androsta-3-one
- AKOS015894892
- ACN-032031
- Androstan-3-one, 17-hydroxy-, (5a,17b)-
- C19-H30-O2
- CCG-267385
- CS-5096
- CS-O-02388
- DB02901
- EBD2157869
- FA17912
- GS-6587
- (5-alpha,17-beta)-17-Hydroxyandrostan-3-one
- (5a,17b)-17-Hydroxyandrostan-3-one
- 17beta Hydroxy 5alpha Androstan 3 One
- 5-(4-Methoxyphenyl)pyrimidin-2-ylamine
- 5.alpha.,17.beta.-Hydroxyandrostan-3-one
- Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-
- Androstanolone (1mg/ml in Acetonitrile)
- NCGC00091013-02
- NCGC00091013-03
- NCGC00257456-01
- NCGC00258540-01
- 17 beta Hydroxy 5 beta Androstan 3 One
- 17beta-hydroxy-3-oxo-5alpha-androstanone
- AC-16144
- AC-33095
- AN-45530
- CAS-521-18-6
- J39.503J
- LS-19384
- SC-16121
- SMR000058342
- 5.alpha.-Androstan-3-one, 17.beta.-hydroxy-
- EC 208-307-3
- AB0108935
- Androstan-3-one, (5.alpha.,17.beta.)-
- beta-Hydroxy-5 beta-Androstan-3-One, 17
- Androstanolone (1.0 mg/mL in Acetonitrile)
- NS00005234
- TESTOSTERONE IMPURITY F [EP IMPURITY]
- 17-.beta.-Hydroxy-5-.alpha.-androstan-3-one
- 5alpha-Androstan-17beta-ol-3-one, >=97.5%
- C03917
- D07456
- Dihydrotestosterone; Testosterone EP Impurity F
- Z-2983
- (5beta,8alpha,17beta)-17-hydroxyandrostan-3-one
- 521S186
- 5Alpha-Dihydrotestosterone, 1mg/ml in Acetonitrile
- Androstan-3-one, 17-hydroxy-, (5.alpha.,17.beta.)-
- Q411054
- (5.alpha.,17.beta.)-17-Hydroxy-androstan-3-one
- (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
- 17.BETA.-HYDROXY-5.ALPHA.-ANDROSTAN-3-ONE
- 17.BETA.-HYDROXY-5.ALPHA.-ANDROSTANE-3-ONE
- Androstanolone (5alpha-Dihydrotestosterone, Stanolone)
- BRD-K22525962-001-05-0
- (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyltetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
- 17-Hydroxyandrostan-3-one, (5.alpha.,17.beta.)- #
- Dihydrotestosterone Solution in Acetonitrile, 100ug/mL
- 5alpha-Androstan-17beta-ol-3-one, purum, >=99.0% (TLC)
- (1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one
- (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one
- 5alpha-Androstan-17beta-ol-3-one, VETRANAL(TM), analytical standard
- Androstanolone (5alpha-Dihydrotestosterone, Stanolone) 1.0 mg/ml in Acetonitrile
- (1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadecan-5-one
- (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-7-one
- (5S,8R,10S,13S,17S)-17-Hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-one
- (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta(a)phenanthren-3-one
- 17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,10,11,12,13,14,15,16, 17-hexadecahydrocyclopenta[a]phenanthren-3-one
- 208-307-3
- 31408-47-6
- 5alpha-Dihydrotestosterone (DHT) solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
- Androstanolone; 17beta-Hydroxy-5alpha-androstan-3-one; Stanolone; Testosterone Imp. F (EP); 5alpha-Dihydrotestosterone; Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-; 5alpha-Androstan-3-one, 17beta-hydroxy- (8CI); (5alpha,17beta)-17-Hydroxyandrostan-3-one; (+)-Androstan-17beta-ol-3-one; 17beta-Hydroxy-3-androstanone; 17beta-Hydroxy-5alpha-androstane-3-one; 4,5alpha-Dihydrotestosterone; 4-Dihydrotestosterone; 5-DHT; 5alpha,17beta-Hydroxyandrostan-3-one; 5alpha-Androstan-17beta-ol-3-one; 5alpha-Androstanolone; Anaboleen; Anabolex; Andractim; Androlone; Androstan-17beta-ol-3-one; Cristerona MB; DHT; Dihydrotestosterone; LG 152; NSC 10972; Neodrol; Stanaprol; Testosterone Impurity F